Polyethyleneimine-lipid conjugate-based pH-sensitive micellar carrier for gene delivery

被引:84
作者
Sawant, Rupa R. [1 ]
Sriraman, Shravan Kumar [1 ]
Navarro, Gemma [1 ]
Biswas, Swati [1 ]
Dalvi, Riddhi A. [1 ]
Torchilin, Vladimir P. [1 ]
机构
[1] Northeastern Univ, Ctr Pharmaceut Biotechnol & Nanomed, Boston, MA 02115 USA
关键词
Polyethyleneimine; Transfection; pH-sensitive; Micelles; Cancer; PLASMID DNA; IN-VITRO; POLY(ETHYLENE GLYCOL); PHYSICAL-PROPERTIES; TRANSFECTION; DESIGN; ACID; POLYETHYLENIMINES; POLYPLEXES; COMPLEXES;
D O I
10.1016/j.biomaterials.2011.11.088
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
A low molecular weight polyethyleneimine (PEI 1.8 kDa) was modified with dioleoylphosphatidylethanolamine (PE) to form the PEI-PE conjugate investigated as a transfection vector. The optimized PEI-PE/pDNA complexes at an N/P ratio of 16 had a particle size of 225 nm, a surface charge of +31 mV, and protected the pDNA from the action of DNase I. The PEI-PE conjugate had a critical micelle concentration (CMC) of about 34 mu g/ml and exhibited no toxicity compared to a high molecular weight PEI (PEI 25 kDa) as tested with B16-F10 melanoma cells. The B16-F10 cells transfected with PEI-PE/pEGFP complexes showed protein expression levels higher than with PEI-1.8 or PEI-25 vectors. Complexes prepared with YOYO 1-labeled pEGFP confirmed the enhanced delivery of the plasmid with PEI-PE compared to PEI-1.8 and PEI-25. The PEI-PE/pDNA complexes were also mixed with various amounts of micelle-forming material, polyethylene glycol (PEG)-PE to improve biocompatibility. The resulting particles exhibited a neutral surface charge, resistance to salt-induced aggregation, and good transfection activity in the presence of serum in complete media. The use of the low-pH-degradable PEG-hydrazone-PE produced particles with transfection activity sensitive to changes in pH consistent with the relatively acidic tumor environment. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3942 / 3951
页数:10
相关论文
共 51 条
  • [1] Biodegradable poly (ethylenimine) for plasmid DNA delivery
    Ahn, CH
    Chae, SY
    Bae, YH
    Kim, SW
    [J]. JOURNAL OF CONTROLLED RELEASE, 2002, 80 (1-3) : 273 - 282
  • [2] Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis
    Akinc, A
    Thomas, M
    Klibanov, AM
    Langer, R
    [J]. JOURNAL OF GENE MEDICINE, 2005, 7 (05) : 657 - 663
  • [3] Formulation and Delivery of siRNA by Oleic Acid and Stearic Acid Modified Polyethylenimine
    Alshamsan, Aws
    Haddadi, Azita
    Incani, Vanessa
    Samuel, John
    Lavasanifar, Afsaneh
    Uludag, Hasan
    [J]. MOLECULAR PHARMACEUTICS, 2009, 6 (01) : 121 - 133
  • [4] Synthesis and gene transfection efficacies of PEI-cholesterol-based lipopolymers
    Bajaj, Avinash
    Kondaiah, Paturu
    Bhattacharya, Santanu
    [J]. BIOCONJUGATE CHEMISTRY, 2008, 19 (08) : 1640 - 1651
  • [5] Folate-PEG-folate-graft-polyethylenimine-based gene delivery
    Benns, JM
    Maheshwari, A
    Furgeson, DY
    Mahato, RI
    Kim, SW
    [J]. JOURNAL OF DRUG TARGETING, 2001, 9 (02) : 123 - +
  • [6] Intracellular route and transcriptional competence of polyethylenimine-DNA complexes
    Bieber, T
    Meissner, W
    Kostin, S
    Niemann, A
    Elsasser, HP
    [J]. JOURNAL OF CONTROLLED RELEASE, 2002, 82 (2-3) : 441 - 454
  • [7] A VERSATILE VECTOR FOR GENE AND OLIGONUCLEOTIDE TRANSFER INTO CELLS IN CULTURE AND IN-VIVO - POLYETHYLENIMINE
    BOUSSIF, O
    LEZOUALCH, F
    ZANTA, MA
    MERGNY, MD
    SCHERMAN, D
    DEMENEIX, B
    BEHR, JP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) : 7297 - 7301
  • [8] PEI-based vesicle-polymer hybrid gene delivery system with improved biocompatibility
    Brownlie, A
    Uchegbu, IF
    Schätzlein, AG
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 274 (1-2) : 41 - 52
  • [9] Overcoming the nuclear barrier:: Cell cycle independent nonviral gene transfer with linear polyethylenimine or electroporation
    Brunner, S
    Fürtbauer, E
    Sauer, T
    Kursa, M
    Wagner, E
    [J]. MOLECULAR THERAPY, 2002, 5 (01) : 80 - 86
  • [10] Erbacher P, 1999, J GENE MED, V1, P210